ArticleFrontiers in medicine2026
DeepInsight-Net: a CBAM-enhanced ResNet50 framework with focal loss for robust cervical cancer classification on multi-center datasets.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cervical cancer remains one of the leading causes of gynecological mortality worldwide, largely due to the limitations of manual cytological screening, which is time-consuming and susceptible to inter-observer variability. Although deep learning has demonstrated strong potential for automating cervical cytopathology, existing Convolutional Neural Network (CNN) models are hindered by two critical challenges: Methods: To address these limitations, we propose DeepInsight-Net, a robust three-stage deep learning framework for cervical cell classification. The core architecture integrates Convolutional Block Attention Modules (CBAM) into a ResNet50 backbone to enhance spatial and channel-wise feature discrimination, enabling the network to selectively emphasize nuclear and nuclear-cytoplasmic boundary regions while suppressing irrelevant background noise. To further mitigate class imbalance, the conventional cross-entropy loss is replaced with Focal Loss, which dynamically down-weights easily classified samples and prioritizes hard, misclassified instances during training. Results: Extensive experiments conducted on the benchmark SiPaKMeddataset demonstrate that DeepInsight-Net achieves a state-of-the-art classification accuracy of 99.63%, outperforming 15 competitive deep learning models, including EfficientNet-B6 and DenseNet169. Moreover, cross-dataset generalization experiments on an independent Liquid-Based Cytology (LBC) dataset yield an accuracy of 98.62%, confirming the robustness and domain adaptability of the proposed framework. Visual interpretability analyses using Grad-CAM and t-SNE reveal that the model consistently focuses on biologically relevant cellular regions, supporting the reliability of its predictions. Conclusion: The proposed DeepInsight-Net effectively addresses spatial irrelevance and class imbalance in cervical cytology analysis through attention-guided feature learning and loss re-weighting. The strong performance across multiple datasets, combined with transparent visual explainability, highlights its potential as a reliable computer-aided diagnosis (CAD) tool for supporting cervical cancer screening in real-world clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.